Working… Menu

Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02400788
Recruitment Status : Completed
First Posted : March 27, 2015
Last Update Posted : January 16, 2018
Information provided by (Responsible Party):
Yakult Honsha Co., LTD

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 2016
Actual Study Completion Date : October 2016